PV pharm branch, vendor, cage 0U9U0
Ended Awarded
- Contract number
- SPE2D826FAU32
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $12,659
Award facts
- Contract value 100% obligated
- $12,659.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On November 1, 2025, the Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $12,659.24 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, set to conclude by November 3, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order is a non-competitive award that leverages the existing prime vendor agreement, which authorizes AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military and federal healthcare systems globally.
Under this delivery order and its parent IDC, AmerisourceBergen supplies critical medical commodities including brand-name and generic medications, specialty pharmaceuticals, vaccines, medical devices, and associated supplies across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio demonstrates consistent capability in fulfilling diverse pharmaceutical procurement requirements, ranging from routine medications to specialized healthcare commodities. The DLA Medical Supply Chain continues to evaluate the Pharmaceutical Prime Vendor Global Program Generation V contracts with plans for multiple regional awards involving different contractors, positioning AmerisourceBergen as a key strategic supplier within the military medical logistics network.
Quick answers
Who was awarded contract SPE2D826FAU32?
SPE2D826FAU32 was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on November 1, 2025.
How much is contract SPE2D826FAU32 worth?
The government has obligated $12,659 on SPE2D826FAU32.
Is contract SPE2D826FAU32 an order under another contract?
Yes. SPE2D826FAU32 is a delivery order under SPE2DX22D0010, an indefinite delivery contract.
Was contract SPE2D826FAU32 competed?
The extent of competition for SPE2D826FAU32 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award